2017 Section 7 Green Book

oropharynx carcinoma

. Oral Surg Oral Med Oral Pathol Oral Radiol Endod . 2009;108(6):933-938 .

. Kovács AF, Döbert N, Gaa J, Menzel C, Bitter K.

Positron emission tomography in combination with

sentinel node biopsy reduces the rate of elective

neck dissections in the treatment of oral and

oropharyngeal cancer.

J Clin Oncol . 2004;22(19): 3973-3980 .

. Wallowy P, Diener J, Grünwald F, Kovács AF.

18F-FDG PET for detecting metastases and

synchronous primary malignancies in patients with

oral and oropharyngeal cancer

. Nuklearmedizin . 2009;48(5):192-199 .

. Chan SC, Wang HM, Yen TC, et al.

¹⁸

F-FDG

PET/CT and 3.0-T whole-body MRI for the detection

of distant metastases and second primary tumours

in patients with untreated oropharyngeal/

hypopharyngeal carcinoma: a comparative study.

Eur J Nucl Med Mol Imaging . 2011;38(9):1607-1619 .

. Hujala K, Sipilä J, Grenman R. Panendoscopy

and synchronous second primary tumors in head

and neck cancer patients

. Eur Arch Otorhinolaryngol . 2005;262(1):17-20 .

. Krabbe CA, Pruim J, Dijkstra PU, et al. 18F-FDG

PET as a routine posttreatment surveillance tool in

oral and oropharyngeal squamous cell carcinoma:

a prospective study

. J Nucl Med . 2009;50(12): 1940-1947 .

. van der Haring IS, Schaapveld MS, Roodenburg

JL, de Bock GH. Second primary tumours after a

squamous cell carcinoma of the oral cavity or

oropharynx using the cumulative incidence

method.

Int J Oral Maxillofac Surg . 2009;38(4):332- 338 .

. Haerle SK, Strobel K, Hany TF, Sidler D, Stoeckli

SJ.

F-FDG-PET/CT versus panendoscopy for the

detection of synchronous second primary tumors in

patients with head and neck squamous cell

carcinoma.

Head Neck . 2010;32(3):319-325 .

. Morris LG, Sikora AG, Patel SG, Hayes RB, Ganly

I. Second primary cancers after an index head and

neck cancer: subsite-specific trends in the era of

human papillomavirus-associated oropharyngeal

cancer.

J Clin Oncol . 2011;29(6):739-746 .

. Gan SJ, Dahlstrom KR, Peck BW, et al. Incidence

and pattern of second primary malignancies in

patients with index oropharyngeal cancers versus

index nonoropharyngeal head and neck cancers.

Cancer . 2013;119(14):2593-2601 .

. Rodriguez-Bruno K, Ali MJ, Wang SJ. Role of

panendoscopy to identify synchronous second

primary malignancies in patients with oral cavity

and oropharyngeal squamous cell carcinoma.

Head Neck . 2011;33(7):949-953 .

. Subramaniam RM, Agarwal A, Colucci A,

Ferraro R, Paidpally V, Mercier G. Impact of

concurrent diagnostic level CT with PET/CT on the

utilization of stand-alone CT and MRI in the

management of head and neck cancer patients

. Clin Nucl Med . 2013;38(10):790-794 .

. Kovalchuk N, Jalisi S, Subramaniam RM, Truong

MT. Deformable registration of preoperative

PET/CT with postoperative radiation therapy

planning CT in head and neck cancer

. Radiographics . 2012;32(5):1329-1341 .

. Chatterjee S, Frew J, Mott J, et al. Variation in

radiotherapy target volume definition, dose to

organs at risk and clinical target volumes using

anatomic (computed tomography) versus

combined anatomic and molecular imaging

(positron emission tomography/computed

tomography): intensity-modulated radiotherapy

delivered using a tomotherapy Hi Art machine: final

results of the VortigERN study

. Clin Oncol (R Coll Radiol) . 2012;24(10):e173-e179 .

. Troost EG, Bussink J, Hoffmann AL, Boerman

OC, Oyen WJ, Kaanders JH. 18F-FLT PET/CT for

early response monitoring and dose escalation in

oropharyngeal tumors

. J Nucl Med . 2010;51(6): 866-874 .

. Subramaniam RM, Truong M, Peller P, Sakai O,

Mercier G. Fluorodeoxyglucose-positron-emission

tomography imaging of head and neck squamous

cell cancer

. AJNR Am J Neuroradiol . 2010;31(4):598- 604 .

. Menda Y, GrahamMM. Update on

18F-fluorodeoxyglucose/positron emission

tomography and positron emission

tomography/computed tomography imaging of

squamous head and neck cancers

. Semin Nucl Med . 2005;35(4):214-219 .

. Paulino AC, Koshy M, Howell R, Schuster D,

Davis LW. Comparison of CT- and FDG-PET-defined

gross tumor volume in intensity-modulated

radiotherapy for head-and-neck cancer

. Int J Radiat Oncol Biol Phys . 2005;61(5):1385-1392 .

. Ciernik IF, Dizendorf E, Baumert BG, et al.

Radiation treatment planning with an integrated

positron emission and computer tomography

(PET/CT): a feasibility study

. Int J Radiat Oncol Biol Phys . 2003;57(3):853-863 .

. Marcus C, Ciarallo A, Tahari AK, et al. Head and

neck PET/CT: therapy response interpretation

criteria (Hopkins criteria)—interreader reliability,

accuracy, and survival outcomes

. J Nucl Med . 2014; 55(9):1411-1416 .

. Isles MG, McConkey C, Mehanna HM. A

systematic review and meta-analysis of the role of

positron emission tomography in the follow up of

head and neck squamous cell carcinoma following

radiotherapy or chemoradiotherapy

. Clin Otolaryngol . 2008;33(3):210-222 .

. Sjövall J, Brun E, Almquist H, Kjellén E,

Wahlberg P. Radiotherapy response in head and

neck cancer—evaluation of the primary tumour site.

Acta Otolaryngol . 2014;134(6):646-651 .

. Kim SY, Lee SW, Nam SY, et al. The feasibility of

18F-FDG PET scans 1 month after completing

radiotherapy of squamous cell carcinoma of the

head and neck.

J Nucl Med . 2007;48(3):373-378 .

. Porceddu SV, Pryor DI, Burmeister E, et al.

Results of a prospective study of positron emission

tomography-directed management of residual

nodal abnormalities in node-positive head and neck

cancer after definitive radiotherapy with or without

systemic therapy.

Head Neck . 2011;33(12):1675-1682 .

. Fakhry C, Zhang Q, Nguyen-Tan PF, et al.

Human papillomavirus and overall survival after

progression of oropharyngeal squamous cell

carcinoma

. J Clin Oncol . 2014;32(30):3365-3373 .

. Chen AY, Vilaseca I, Hudgins PA, Schuster D,

Halkar R. PET-CT vs contrast-enhanced CT: what is

the role for each after chemoradiation for advanced

oropharyngeal cancer?

Head Neck . 2006;28(6): 487-495 .

. Ng SH, Chan SC, Yen TC, et al. PET/CT and 3-T

whole-body MRI in the detection of malignancy in

treated oropharyngeal and hypopharyngeal

carcinoma

. Eur J Nucl Med Mol Imaging . 2011;38(6): 996-1008 .

. Koshkareva Y, Branstetter BF IV, Gaughan JP,

Ferris RL. Predictive accuracy of first posttreatment

PET/CT in HPV-related oropharyngeal squamous

cell carcinoma.

Laryngoscope

. 2014;124(8):1843-1847.

. Moon SH, Choi JY, Lee HJ, et al. Prognostic

value of 18F-FDG PET/CT in patients with squamous

cell carcinoma of the tonsil: comparisons of

volume-based metabolic parameters

. Head Neck . 2013;35(1):15-22 .

. Alluri KC, Tahari AK, Wahl RL, Koch W, Chung

CH, Subramaniam RM. Prognostic value of FDG PET

metabolic tumor volume in human

papillomavirus-positive stage III and IV

oropharyngeal squamous cell carcinoma

. AJR Am J Roentgenol . 2014;203(4):897-903 .

. Cheng NM, Fang YH, Chang JT, et al. Textural

features of pretreatment 18F-FDG PET/CT images:

prognostic significance in patients with advanced

T-stage oropharyngeal squamous cell carcinoma.

J Nucl Med . 2013;54(10):1703-1709 .

. Cheng NM, Chang JT, Huang CG, et al.

Prognostic value of pretreatment

¹⁸

F-FDG PET/CT

and human papillomavirus type 16 testing in locally

advanced oropharyngeal squamous cell carcinoma.

Eur J Nucl Med Mol Imaging . 2012;39(11):1673-1684 .

. Kikuchi M, Koyasu S, Shinohara S, et al.

Prognostic value of pretreatment

F-fluorodeoxyglucose positron emission

tomography/CT volume-based parameters in

patients with oropharyngeal squamous cell

carcinoma with known p16 and p53 status.

Head

Neck

. 2015;37(10):1524-1531.

Use of FDG-PET/CT in Oropharyngeal Squamous Cell Carcinoma

Review

Clinical Review & Education

jamaotolaryngology.com

(Reprinted)

JAMA Otolaryngology–Head & Neck Surgery

January 2016 Volume 142, Number 1